Diego is a skilled start-up executive, engineer, and scientist with extensive experience leading research efforts to develop products that help patients and physicians overcome healthcare obstacles. Prior to co-founding Endpoint Health, Diego invented the core technology and led investigational efforts related to Roche’s antibiotic therapy guidance research and development. Prior to Roche, Diego co-founded GeneWEAVE, a diagnostics company that developed rapid tests to detect and guide therapy choice for serious infections, which was acquired by Roche in 2015.
Diego received a BS in Electrical Engineering from UC Santa Barbara and an MS and PhD in Biomedical Engineering from Cornell University.
Diego is a co-founder, board member, and Chief Scientific Officer of Endpoint Health. He employs his background in building multidisciplinary technical teams to create and develop the core technologies that enable Endpoint Health to deliver products to improve patient care.